Search Results

Pharmacogenetics of Phase I and Phase II Drug Metabolism

Authors: Crettol, Severine; Petrovic, Nenad; Murray, Michael

Source: Current Pharmaceutical Design, Volume 16, Number 2, January 2010 , pp. 204-219(16)

Publisher: Bentham Science Publishers

Glucocorticoids and phenobarbital induce murine CYP2B genes by independent mechanisms

Authors: Audet-Walsh, Étienne; Auclair-Vincent, Sacha; Anderson, Alan

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1501-1511(11)

Publisher: Informa Healthcare

Editorial [Special Board Members Issue]

Author: Prakash, Chandra

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 659-660(2)

Publisher: Bentham Science Publishers

Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance

Authors: Wang, Bo; Wang, Jing; Huang, Shui-Qing; Su, Hai-Hao; Zhou, Shu-Feng

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 781-834(54)

Publisher: Bentham Science Publishers

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 11, 1 November 2009 , pp. 689-723(35)

Publisher: Adis International

Pharmacogenomics and therapeutic strategies for dementia

Author: Cacabelos, Ramón

Source: Expert Review of Molecular Diagnostics, Volume 9, Number 6, September 2009 , pp. 567-611(45)

Publisher: Expert Reviews

The gene road to royalty - differential expression of hydroxylating genes in the mandibular glands of the honeybee

Authors: Malka, Osnat; Karunker, Iris; Yeheskel, Adva; Morin, Shai; Hefetz, Abraham

Source: FEBS Journal, Volume 276, Number 19, October 2009 , pp. 5481-5490(10)

Publisher: Blackwell Publishing

Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy

Authors: Killer, Nina; Hock, Monika; Gehlhaus, Marcel; Capetian, Philipp; Knoth, Rolf; Pantazis, Georgios; Volk, Benedikt; Meyer, Ralf P.

Source: Epilepsia, Volume 50, Number 8, August 2009 , pp. 1875-1890(16)

Publisher: Blackwell Publishing

Transcriptional Regulation of Cytochrome P450 Genes by the Nuclear Receptor Hepatocyte Nuclear Factor 4-Alpha

Authors: Jover, Ramiro; Moya, Marta; Gomez-Lechon, M. J.

Source: Current Drug Metabolism, Volume 10, Number 5, June 2009 , pp. 508-519(12)

Publisher: Bentham Science Publishers

QSAR models for P450 (2D6) substrate activity

Authors: Ringsted, T.; Nikolov, N.; Jensen, G. E.; Wedebye, E. B.; Niemela, J.

Source: SAR and QSAR in Environmental Research, Volume 20, Numbers 3-4, April 2009 , pp. 309-325(17)

Publisher: Taylor and Francis Ltd

Polymorphism of human cytochrome P450 enzymes and its clinical impact

Authors: Zhou, Shu-Feng; Liu, Jun-Ping; Chowbay, Balram

Source: Drug Metabolism Reviews, Volume 41, Number 2, May 2009 , pp. 89-295(207)

Publisher: Informa Healthcare

Pharmacological and metabolic characterisation of the potent σ₁ receptor ligand 1′-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4′-piperidine]

Authors: Wiese, Christian; Maestrup, Eva Große; Schepmann, Dirk; Vela, Jose Miguel; Holenz, Jörg; Buschmann, Helmut; Wünsch, Bernhard

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 5, May 2009 , pp. 631-640(10)

Publisher: Pharmaceutical Press

Characterization and expression of extrahepatic CYP2S1

Authors: Deb, Subrata; Bandiera, Stelvio M

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 4, April 2009 , pp. 367-380(14)

Publisher: Informa Healthcare

CYP2B6 (c.516G→T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients

Authors: Kwara, Awewura; Lartey, Margaret; Sagoe, Kwamena W.; Rzek, Naser L.; Court, Michael H.

Source: British Journal of Clinical Pharmacology, Volume 67, Number 4, April 2009 , pp. 427-436(10)

Publisher: Blackwell Publishing

Mode of Action Analysis for the Synthetic Pyrethroid Metofluthrin-Induced Rat Liver Tumors: Evidence for Hepatic CYP2B Induction and Hepatocyte Proliferation

Authors: Deguchi, Yoshihito; Yamada, Tomoya; Hirose, Yukihiro; Nagahori, Hirohisa; Kushida, Masahiko; Sumida, Kayo; Sukata, Tokuo; Tomigahara, Yoshitaka; Nishioka, Kazuhiko; Uwagawa, Satoshi; Kawamura, Satoshi; Okuno, Yasuyoshi

Source: Toxicological Sciences, Volume 108, Number 1, 23 March 2009 , pp. 69-80(12)

Publisher: Oxford University Press

Roles of Coactivator Proteins in Dioxin Induction of CYP1A1 and CYP1B1 in Human Breast Cancer Cells

Authors: Taylor, Robert T.; Wang, Feng; Hsu, Erin L.; Hankinson, Oliver

Source: Toxicological Sciences, Volume 107, Number 1, 17 January 2009 , pp. 1-8(8)

Publisher: Oxford University Press

Pharmacogenetics of Tamoxifen: Who Should Undergo CYP2D6 Genetic Testing?

Authors: Higgins, Michaela J.; Rae, James M.; Flockhart, David A.; Hayes, Daniel F.; Stearns, Vered

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 2, February 2009 , pp. 203-213(11)

Publisher: Cold Spring Publishing, LLC

Effects of Tributyltin (TBT) on In Vitro Hormonal and Biotransformation Responses in Atlantic Salmon (Salmo salar)

Authors: Mortensen, Anne; Arukwe, Augustine

Source: Journal of Toxicology and Environmental Health Part A, Volume 72, Numbers 3-4, 2009 , pp. 209-218(10)

Publisher: Taylor and Francis Ltd

Cytochrome P450 and the Biological Clock in Mammals

Author: Froy, Oren

Source: Current Drug Metabolism, Volume 10, Number 2, February 2009 , pp. 104-115(12)

Publisher: Bentham Science Publishers

Preclinical pharmacokinetics of MK-0974, an orally active calcitonin-gene related peptide (CGRP)-receptor antagonist, mechanism of dose dependency and species differences

Authors: Roller, S.; Cui, D.; Laspina, C.; Miller-Stein, C.; Rowe, J.; Wong, B.; Prueksaritanont, T.

Source: Xenobiotica, Volume 39, Number 1, January 2009 , pp. 33-45(13)

Publisher: Informa Healthcare